Quick Answer
Serina Therapeutics, Inc. reported Total Revenue of $130.0 thousand for fiscal year 2025.
Serina Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $130.0K | +132.1% |
| 2024 | $56.0K | -98.2% |
| 2023 | $3.15M | +9173.5% |
| 2022 | $34.0K | -76.4% |
| 2021 | $144.0K | -60.1% |
| 2020 | $361.0K | -79.1% |
| 2019 | $1.73M | +23.8% |
| 2018 | $1.40M | -0.6% |
| 2017 | $1.40M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | -100.0% | -100.0% |
| June 30, 2025 | $130.0K | +154.9% | — |
| March 31, 2025 | $0.00 | -100.0% | -100.0% |
| September 30, 2024 | $14.0K | -51.7% | -72.5% |
| June 30, 2024 | $51.0K | +628.6% | +920.0% |
| March 31, 2024 | $5.0K | -83.3% | -82.8% |
| September 30, 2023 | $29.0K | +222.2% | +314.3% |
| June 30, 2023 | $7.0K | -41.7% | -76.7% |
- Serina Therapeutics, Inc. showed an increase of +132.1% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Serina Therapeutics, Inc.’s total revenue has declined by 90.7% (from $1.40 million to $130.0 thousand).
- The most recent figure is from Serina Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: